75 related articles for article (PubMed ID: 8536215)
1. Growth inhibitory action of brefeldin A with taxol and tiazofurin in human breast carcinoma cells.
Yeh YA; Weber G
Cancer Biochem Biophys; 1995 Jun; 15(1):11-7. PubMed ID: 8536215
[TBL] [Abstract][Full Text] [Related]
2. Synergistic action of taxol with tiazofurin and methotrexate in human breast cancer cells: schedule-dependence.
Yeh YA; Olah E; Wendel JJ; Sledge GW; Weber G
Life Sci; 1994; 54(24):PL431-5. PubMed ID: 7910932
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms in the antiproliferative action of taxol and tiazofurin.
Olah E; Csokay B; Prajda N; Kote-Jarai Z; Yeh YA; Weber G
Anticancer Res; 1996; 16(5A):2469-77. PubMed ID: 8917337
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen downregulates signal transduction and is synergistic with tiazofurin in human breast carcinoma MDA-MB-435 cells.
Shen F; Weber G
Oncol Res; 1998; 10(6):325-31. PubMed ID: 9848103
[TBL] [Abstract][Full Text] [Related]
5. Synergistic action of taxol and tiazofurin in human ovarian, pancreatic and lung carcinoma cells.
Taniki T; Prajda N; Monden Y; Weber G
Cancer Biochem Biophys; 1993 Sep; 13(4):295-302. PubMed ID: 8521379
[TBL] [Abstract][Full Text] [Related]
6. Synergistic action of tiazofurin and genistein in human ovarian carcinoma cells.
Li W; Weber G
Oncol Res; 1998; 10(3):117-22. PubMed ID: 9700722
[TBL] [Abstract][Full Text] [Related]
7. Synergism of taxol and gallium nitrate in human breast carcinoma cells: schedule dependency.
Hata Y; Sandler A; Loehrer PJ; Sledge GW; Weber G
Oncol Res; 1994; 6(1):19-24. PubMed ID: 7919548
[TBL] [Abstract][Full Text] [Related]
8. Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than taxol.
ter Haar E; Kowalski RJ; Hamel E; Lin CM; Longley RE; Gunasekera SP; Rosenkranz HS; Day BW
Biochemistry; 1996 Jan; 35(1):243-50. PubMed ID: 8555181
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.
Nielsen LL; Lipari P; Dell J; Gurnani M; Hajian G
Clin Cancer Res; 1998 Apr; 4(4):835-46. PubMed ID: 9563876
[TBL] [Abstract][Full Text] [Related]
10. Effect of selenium in combination with Adriamycin or Taxol on several different cancer cells.
Vadgama JV; Wu Y; Shen D; Hsia S; Block J
Anticancer Res; 2000; 20(3A):1391-414. PubMed ID: 10928049
[TBL] [Abstract][Full Text] [Related]
11. Rhein lysinate suppresses the growth of breast cancer cells and potentiates the inhibitory effect of Taxol in athymic mice.
Lin YJ; Zhen YS
Anticancer Drugs; 2009 Jan; 20(1):65-72. PubMed ID: 19343002
[TBL] [Abstract][Full Text] [Related]
12. Synergism between the anticancer actions of 2-methoxyestradiol and microtubule-disrupting agents in human breast cancer.
Han GZ; Liu ZJ; Shimoi K; Zhu BT
Cancer Res; 2005 Jan; 65(2):387-93. PubMed ID: 15695378
[TBL] [Abstract][Full Text] [Related]
13. Taxol and cisplatin inhibit proliferation of T47D human breast cancer cells.
Kodali S; Burkley M; Nag K; Taylor RC; Moudgil VK
Biochem Biophys Res Commun; 1994 Aug; 202(3):1413-9. PubMed ID: 7914723
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Fatty Acid Synthase (FASN) synergistically enhances the efficacy of 5-fluorouracil in breast carcinoma cells.
Vazquez-Martin A; Ropero S; Brunet J; Colomer R; Menendez JA
Oncol Rep; 2007 Oct; 18(4):973-80. PubMed ID: 17786362
[TBL] [Abstract][Full Text] [Related]
15. Tiazofurin: molecular and clinical action.
Weber G; Prajda N; Abonyi M; Look KY; Tricot G
Anticancer Res; 1996; 16(6A):3313-22. PubMed ID: 9042306
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of brefeldin A sulfide derivatives as prodrug candidates with enhanced aqueous solubilities.
Argade AB; Devraj R; Vroman JA; Haugwitz RD; Hollingshead M; Cushman M
J Med Chem; 1998 Aug; 41(18):3337-46. PubMed ID: 9719586
[TBL] [Abstract][Full Text] [Related]
17. Schedule-dependent synergism and antagonism between paclitaxel and methotrexate in human carcinoma cell lines.
Kano Y; Akutsu M; Tsunoda S; Furuta M; Yazawa Y; Ando J
Oncol Res; 1998; 10(7):347-54. PubMed ID: 10063968
[TBL] [Abstract][Full Text] [Related]
18. Resistance of cultured Lewis lung carcinoma cell lines to tiazofurin.
Finlay GJ; Ching LM; Wilson WR; Baguley BC
J Natl Cancer Inst; 1987 Aug; 79(2):291-6. PubMed ID: 3474463
[TBL] [Abstract][Full Text] [Related]
19. Suppression of centromere dynamics by Taxol in living osteosarcoma cells.
Kelling J; Sullivan K; Wilson L; Jordan MA
Cancer Res; 2003 Jun; 63(11):2794-801. PubMed ID: 12782584
[TBL] [Abstract][Full Text] [Related]
20. Synergistic action of tiazofurin and genistein on growth inhibition and differentiation of K-562 human leukemic cells.
Li W; Weber G
Life Sci; 1998; 63(22):1975-81. PubMed ID: 9839541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]